New York: The US Food and Drug Administration approved antiviral drug Remdisivir for treating the COVID-19 patients in the country.
The drug reportedly shortened the recovery time by 31 per cent or about four days for the patients admitted to the hospital.
Having manufactured by Gilead Sciences, a California based company, the FDA has allowed the use of the medication only during the pandemic.
Remdesivir, the antiviral drug was found to kill viruses like Ebola, Marburg, MERS and SARS. The medication disables virus RNA (ribonucleic acid) replication (through RNA, coronavirus replicates itself)
However, the drug failed the human trial stage for treating the Ebola virus in 2018-19.
Balasore: A young man was allegedly beaten to death on the suspicion of having committed…
Mumbai: Bollywood celebrities have often had funny, at times bizarre experiences, mostly involving hero-worshipping, demanding fans.…
Bhubaneswar: Police have arrested the owner of a Jatra (theatre) group for allegedly duping an…
Sanskriti Talwar Faridkot (Punjab): For the third consecutive year, Balwinder Singh of Mallan village in…
Bhubaneswar: Rain may play spoilsport in Christmas and New Year celebrations in Odisha as the…
New Delhi: Netflix showed the way, Amazon Prime Video is following in their footsteps. Come…
This website uses cookies.